Table 2.
Summary of pre-, during and post evaluations during the study
| Baseline | Weekly treatment visits | Follow Up (2–3 months) | |
|---|---|---|---|
| Physical examination with or without nasoendoscopy | X | X | X |
| Weight and BMI | X | X | X |
| Complete blood count with differential | |||
| - Hemoglobin | |||
| - Neutrophil count | |||
| - Platelet count | |||
| - Monocyte count | X | X | X |
| Basic Metabolic Panel | |||
| - Electrolytes | |||
| - Liver function tests | |||
| - Albumin | |||
| - ESR | |||
| - CRP | X | X | X |
| Blood biomarker collection: | |||
| - 10 ml CellSave tube | |||
| - 2 × 10 ml EDTA tubes | X | X | X |
| Pregnancy test (female of childbearing age) | X | ||
| Contrast CT head and neck | X | X | |
| 18F-FDG PET/CT (optional) | X | X | |
| MRI of the head and neck | X | X | X |